RxDoctor Payments Data

Steven Seung, MD

Radiation Oncology · Portland, ORNPI 1396738431

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,605 of the $10,566 with a category attached, or 72.0%. 15 manufacturers reported payments, led by Elekta, Inc. at 40.6% of the total. Reporting peaked in 2022 at $3,997 and has fallen 55.8% since, to $1,767 in 2025. Among radiation oncology clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,566in general payments, 2019–2025

Across 87 payments — averaging $121.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Elekta, Inc.$4K
  • Viewray Technologies Inc$3K
  • Siemens Medical Solutions USA, Inc.$1K
  • Reflexion Medical, Inc.$608
  • Brainlab, Inc.$297
  • Zap Surgical Systems, Inc.$264
  • plus $616 from 9 others

What the payments were for

  • Travel & lodging$2,96228%
  • Food & beverage$7,60572%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,566 in reported general payments places this provider in the 95th percentile of 93 radiation oncology providers in Oregon.

See all radiation oncology providers in Oregon

Medicare billing

Part B allowed, 2024
$106,528
Medicare patients
208
Services billed
1,247

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron OdtOndansetron14$501
Lidocaine Hcl ViscousLidocaine Hcl16$335
Dexamethasone14$225
Lorazepam11$169
Oxycodone Hcl12$124

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →